Efficacy Study on Cognitive Functions in Schizophrenic Patients

clinical trial

MedicalStudy clinical_trial Q64714823

Press Enter · cited answer in seconds

Summary

Efficacy Study on Cognitive Functions in Schizophrenic Patients is a clinical trial^[1].

Key Facts

Efficacy Study on Cognitive Functions in Schizophrenic Patients is in the country of Hungary^[2].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's instance of is recorded as clinical trial^[3].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's start time is recorded as +2008-09-30T00:00:00Z^[4].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's end time is recorded as +2010-01-31T00:00:00Z^[5].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's main subject is recorded as schizophrenia^[6].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's number of participants is recorded as {'unit': '1', 'amount': '+37'}^[7].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's title is recorded as Comparative Efficacy of Amisulpride vs Risperidone on Cognitive Functions in Patients With Chronic Schizophrenia^[8].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's short name is recorded as AMIMIND^[9].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's ClinicalTrials.gov ID is recorded as NCT00761670^[11].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[12].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's research intervention is recorded as risperidone^[13].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's clinical trial phase is recorded as phase IV clinical trial^[14].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's research site is recorded as Sanofi^[15].
Efficacy Study on Cognitive Functions in Schizophrenic Patients's study type is recorded as interventional study^[16].

⭐ Popularity Graph

0/100 long tail

⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

Medical conditionP1050

schizophrenia 2026-09-26 ClinicalTrials.gov (US Government Public Domain)

ClinicalTrials.gov (data processed by ClinicalTrials.gov on 2026-09-26); U.S. federal government data, public domain; lake licence_code custom-review

Quick Facts

Instance of clinical trial

Country Hungary

Short name AMIMIND

Properties

Clinical trial phase phase IV clinical trial

End time January 31, 2010

Imported from wholeness_audit_2026-05-02

Main subject schizophrenia

Maximum age 65 year

Minimum age 18 year

Number of participants 37

Research intervention risperidone

Research site Sanofi

Start time September 30, 2008

Study type interventional study

Title Comparative Efficacy of Amisulpride vs Risperidone on Cognitive Functions in Patients With Chronic Schizophrenia

External References (1)

Clinicaltrials.gov id NCT00761670

🏷️ Also known as

en Efficacy Study on Cognitive Functions in Schizophrenic Patients

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

Class ancestry

[1] ↑ Efficacy Study on Cognitive Functions in Schizophrenic Patients is an instance of clinical trial (Q30612) [P31, primary]. Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA

4ort.xyz Knowledge Graph. (2026). Efficacy Study on Cognitive Functions in Schizophrenic Patients. Retrieved May 3, 2026, from https://4ort.xyz/entity/efficacy-study-on-cognitive-functions-in-schizophrenic-patients

MLA

“Efficacy Study on Cognitive Functions in Schizophrenic Patients.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/efficacy-study-on-cognitive-functions-in-schizophrenic-patients.

BibTeX

@misc{4ortxyz_efficacy-study-on-cognitive-functions-in-schizophrenic-patients_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Efficacy Study on Cognitive Functions in Schizophrenic Patients}}, year = {2026}, url = {https://4ort.xyz/entity/efficacy-study-on-cognitive-functions-in-schizophrenic-patients}, note = {Accessed: 2026-05-03}}

LLM prompt

According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Efficacy Study on Cognitive Functions in Schizophrenic Patients — https://4ort.xyz/entity/efficacy-study-on-cognitive-functions-in-schizophrenic-patients (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/efficacy-study-on-cognitive-functions-in-schizophrenic-patients · Last refreshed: May 3, 2026